Details for Patent: 10,478,574

✉ Email this page to a colleague

Which drugs does patent 10,478,574 protect, and when does it expire?

Patent 10,478,574 protects ONZETRA XSAIL and XHANCE and is included in two NDAs.

This patent has five patent family members in four countries.

Summary for Patent: 10,478,574

Title:	Nasal administration
Abstract:	A delivery device for and method of providing for delivery of substance to the central nervous system (CNS) of a subject, the delivery device comprising: a nosepiece unit (17) for insertion into a nasal airway (1) of a subject and comprising an outlet unit (21) which includes a nozzle (25) for delivering substance into the nasal airway of the subject; and a substance supply unit which is operable to deliver a dose of substance to the nozzle: wherein the delivery device is configured such that at least 30% of the dose as initially deposited in the nasal airway is deposited in an upper posterior region of the nasal airway, thereby providing a CNS concentration of the substance, and hence CNS effect, which is significantly greater than that which would be predicted from a counterpart blood plasma concentration of the substance.
Inventor(s):	Djupesland; Per Gisle (Oslo, NO), Hafner; Roderick Peter (Wiltshire, GB)
Assignee:	OptiNose AS (Oslo, NO)
Application Number:	12/161,466
Patent Claim Types: see list of patent claims	Use; Composition; Delivery; Device;

Drugs Protected by US Patent 10,478,574

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Currax	ONZETRA XSAIL	sumatriptan succinate	POWDER;NASAL	206099-001	Jan 27, 2016		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				METHOD OF DELIVERING SUMATRIPTAN TO A NASAL CAVITY	⤷ Sign Up
Optinose Us Inc	XHANCE	fluticasone propionate	SPRAY, METERED;NASAL	209022-001	Sep 18, 2017		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 10,478,574

PCT Information
PCT Filed	January 19, 2006	PCT Application Number:	PCT/GB2006/000182
PCT Publication Date:	July 26, 2007	PCT Publication Number:	WO2007/083073

International Family Members for US Patent 10,478,574

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006335994	⤷ Sign Up
Canada	2642608	⤷ Sign Up
European Patent Office	1984049	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.